Functional Outcomes Associated With Blood Pressure Decrease After Endovascular Thrombectomy
Authors: Jung Jae Wook , Kim Kwang Hyun , Yun Jaeseob , Kim Young Dae , Heo JoonNyung , Lee Hyungwoo , Choi Jin Kyo , Lee Il Hyung , Lim In Hwan , Hong Soon-Ho , Kim Byung Moon , Kim Dong Joon , Shin Na Young , Cho Bang-Hoon , Ahn Seong Hwan , Park Hyungjong , Sohn Sung-Il , Hong Jeong-Ho , Song Tae-Jin , Chang Yoonkyung , Kim Gyu Sik , Seo Kwon-Duk , Lee Kijeong , Chang Jun Young , Seo Jung Hwa , Lee Sukyoon , Baek Jang-Hyun , Cho Han-Jin , Shin Dong Hoon , Kim Jinkwon , Yoo Joonsang , Baik Minyoul , Lee Kyung-Yul , Jung Yo Han , Hwang Yang-Ha , Kim Chi Kyung , Kim Jae Guk , Lee Chan Joo , Park Sungha , Jeon Soyoung , Lee Hye Sun , Kwon Sun U. , Bang Oh Young , Heo Ji Hoe , Nam Hyo Suk 
Published: April 2024

Importance

The associations between blood pressure (BP) decreases induced by medication and functional outcomes in patients with successful endovascular thrombectomy remain uncertain.

Objective

To evaluate whether BP reductions induced by intravenous BP medications are associated with poor functional outcomes at 3 months.

Design, Setting, and Participants

This cohort study was a post hoc analysis of the Outcome in Patients Treated With Intra-Arterial Thrombectomy–Optimal Blood Pressure Control trial, a comparison of intensive and conventional BP management during the 24 hours after successful recanalization from June 18, 2020, to November 28, 2022. This study included 302 patients who underwent endovascular thrombectomy, achieved successful recanalization, and exhibited elevated BP within 2 hours of successful recanalization at 19 stroke centers in South Korea.

Exposure

A BP decrease was defined as at least 1 event of systolic BP less than 100 mm Hg. Patients were divided into medication-induced BP decrease (MIBD), spontaneous BP decrease (SpBD), and no BP decrease (NoBD) groups.

Main Outcomes and Measures

The primary outcome was a modified Rankin scale score of 0 to 2 at 3 months, indicating functional independence. Primary safety outcomes were symptomatic intracerebral hemorrhage within 36 hours and mortality due to index stroke within 3 months.

Results

Of the 302 patients (median [IQR] age, 75 [66-82] years; 180 [59.6%] men), 47 (15.6%)were in the MIBD group, 39 (12.9%) were in the SpBD group, and 216 (71.5%) were in the NoBD group. After adjustment for confounders, the MIBD group exhibited a significantly smaller proportion of patients with functional independence at 3 months compared with the NoBD group (adjusted odds ratio [AOR], 0.45; 95% CI, 0.20-0.98). There was no significant difference in functional independence between the SpBD and NoBD groups (AOR, 1.41; 95% CI, 0.58-3.49). Compared with the NoBD group, the MIBD group demonstrated higher odds of mortality within 3 months (AOR, 5.15; 95% CI, 1.42-19.4). The incidence of symptomatic intracerebral hemorrhage was not significantly different among the groups (MIBD vs NoBD: AOR, 1.89; 95% CI, 0.54-5.88; SpBD vs NoBD: AOR, 2.75; 95% CI, 0.76-9.46).

Conclusions and Relevance

In this cohort study of patients with successful endovascular thrombectomy after stroke, MIBD within 24 hours after successful recanalization was associated with poor outcomes at 3 months. These findings suggested lowering systolic BP to below 100 mm Hg using BP medication might be harmful.